Trials in type 1 diabetes: Antigen-specific therapies-Reference-Cited by-同舟云学术

Trials in type 1 diabetes: Antigen-specific therapies

Published:2013-12 Issue:3 Volume:149 Page:345-355
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Coppieters Ken T.,Harrison Leonard C.,von Herrath Matthias G.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference99 articles.

1. Type 1 diabetes: etiology, immunology, and therapeutic strategies;van Belle;Physiol. Rev.,2011

2. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients;Coppieters;J. Exp. Med.,2012

3. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope;Skowera;J. Clin. Invest.,2008

4. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts;Tyden;N. Engl. J. Med.,1996

5. A comprehensive review of interventions in the NOD mouse and implications for translation;Shoda;Immunity,2005

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendritic Cells and Their Immunotherapeutic Potential for Treating Type 1 Diabetes;International Journal of Molecular Sciences;2022-04-28

2. Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes;Diabetology;2022-02-07

3. The parasite-derived peptide FhHDM-1 activates the PI3K/Akt pathway to prevent cytokine-induced apoptosis of β-cells;Journal of Molecular Medicine;2021-08-10

4. Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets;Frontiers in Immunology;2021-04-19

5. Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial;The Lancet Diabetes & Endocrinology;2021-04